SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories reports 31% jump in Q4 net profit

29 May 2012 Evaluate

Ipca Laboratories has reported results for the quarter and year ended March 31, 2012.

The company’s net profit for the fourth quarter ended March 31, 2012 rose 30.80% to Rs 76.61 crore as compared to Rs 58.57 crore for the quarter ended March 31, 2011. The total income has increased by 17.75% to Rs 564.83 crore for the quarter under review from Rs 479.68 crore for the corresponding quarter of the previous year.

For the year ended March 31, 2012, the company’s net profit jumped by 9.71% to Rs 280.17 crore as compared to Rs 255.37 crore for the previous year. The company’s total income has increased by 23.96% to Rs 2342.29 crore for the year from Rs 1889.61 crore in the previous year.

On consolidated basis, the Group’s net profit stood at Rs 277.06 crore for the year under review as compared to Rs 262.82 crore for the period ago, up by 5.42%. Its total income has increased by 24.24% to Rs 2370.68 crore for the year ended March 31, 2012 from Rs 1908.18 crore in the previous year.

In view of the amalgamation of Tonira Pharma with the company effective April 01, 2011, the financial figures for the current quarter / year are not strictly comparable with that of previous quarter / year.

Ipca Laboratories Share Price

1572.00 28.05 (1.82%)
06-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 940.00
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×